U.S. Basic Materials Stock News

Target recently launched “Good & Gather: Discover Delicious Every Day,” a 100-recipe cookbook built around its Good & Gather owned-brand ingredients, all available in-store and online, underscoring its push to make food and beverage a stronger traffic driver. The cookbook effectively turns Target’s test kitchen and Good & Gather range into an integrated meal-planning ecosystem, encouraging guests to shift more everyday grocery and pantry spending to the retailer. We’ll examine how using the...

Credit Acceptance (CACC) is back in focus as investors look ahead to its Q2 2026 earnings release and call on August 4, alongside several recent changes in its executive and board ranks. See our latest analysis for Credit Acceptance. At a share price of US$572.97, Credit Acceptance has seen a 26.23% year to date share price return and a 27.06% total shareholder return over the past year, even as the 30 day share price return declined 12.81%. This suggests that recent leadership changes and...

Vishay Precision Group (VPG) is drawing fresh attention ahead of its second quarter 2026 earnings on August 5, as investors focus on order momentum tied to AI, defense, and robotics demand. See our latest analysis for Vishay Precision Group. At a share price of $91.60, Vishay Precision Group has seen strong momentum over the past year, with the share price return year to date of 133.20% and a one year total shareholder return of 243.59%. This comes even after a 30 day share price decline of...

Integra LifeSciences earnings swing and guidance reset Integra LifeSciences Holdings (IART) has moved from a prior year net loss to a modest profit and paired that with fresh third quarter and full year 2026 revenue guidance. The company reported second quarter 2026 sales of US$418.76 million compared with US$415.61 million a year earlier, with net income of US$4.48 million replacing a prior year net loss of US$484.07 million. See our latest analysis for Integra LifeSciences Holdings. Integra...

Why CDW’s upcoming Q2 report is drawing fresh attention CDW (CDW) is back in focus as investors look ahead to its second quarter 2026 results, with expectations for high single digit EPS growth supported by AI driven demand and a solid backlog. Management also points to growing momentum in professional and managed services, which are expected to add more recurring revenue over time. That mix shift is an important part of how many investors are now thinking about CDW stock. See our latest...

Leadership change and upcoming earnings focus attention on Fortune Brands Innovations Fortune Brands Innovations (FBIN) is in the spotlight after Executive Vice President and Chief Legal Officer Hiranda S. Donoghue decided to leave the company on July 31, 2026. Jack N. Melamed will step in on an interim basis. This leadership transition comes just ahead of the company’s earnings report on Tuesday, where the market expects revenue to decline 3.9% year on year, similar to the 3% decline...

In late July 2026, The Goldman Sachs Group, Inc. issued a wide range of fixed-rate, callable senior and MTN notes across maturities from 2027 to 2046, including multiple tranches in the US$1 million to US$15.52 million range. Alongside these bond offerings, Goldman Sachs drew fresh attention for premium income ETFs outpacing key rivals and for high-profile market commentary on technology valuations, volatility and portfolio construction. We’ll now examine how Goldman’s active bond issuance...

The United States market has recently experienced a 2.4% climb over the past week and a notable 20% increase over the last year, with earnings projected to grow by 17% annually in the coming years. In such an environment, identifying stocks that are potentially priced below their estimated value can be crucial for investors aiming to capitalize on future growth opportunities.

The United States market has shown robust performance, rising 2.4% over the last week and climbing 20% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often indicate confidence from those closest to the business's operations and future prospects.

The United States market has shown robust performance, with a 2.4% increase over the last week and a 20% rise over the past year, alongside forecasts of annual earnings growth at 17%. Penny stocks, though an older term, continue to hold relevance as they often represent smaller or newer companies that can offer significant growth potential at lower price points. By focusing on those with strong balance sheets and solid fundamentals, investors may find opportunities for upside while mitigating...

The United States market has shown a robust performance recently, climbing 2.4% in the last week and 20% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this dynamic environment, identifying stocks that are not only positioned for growth but also remain under-the-radar can offer intriguing opportunities for investors seeking to diversify their portfolios.

In July 2026, Pulse Biosciences, Inc. reported that its pivotal NANOPULSE-AF Study of the nPulse System for atrial fibrillation had passed the enrollment midpoint, highlighting rapid recruitment since the study’s April 2026 start and real-world alignment with first-line ablation practice. This pace of enrollment, supported by early safety and efficacy signals and an intuitive nano-PFA catheter, underscores growing clinician enthusiasm for the nPulse platform in a competitive cardiac ablation...

American Homes 4 Rent (AMH) is back in focus after reporting higher year over year sales, net income and earnings per share for the second quarter and first half of 2026. See our latest analysis for American Homes 4 Rent. The recent earnings update appears to have supported buying interest in American Homes 4 Rent, with a 1-day share price return of 3.26% and a year to date share price return of 8.11%. Over the past five years, however, the total shareholder return of a 3.36% decline points...

Automatic Data Processing, Inc. has reported its fourth-quarter and full-year 2026 results, with quarterly sales of US$3,342.1 million, revenue of US$5,473.8 million, and net income of US$978.6 million, all higher than a year earlier, and full-year revenue rising to US$21.95 billion with earnings per share also increasing. Beyond the headline growth, management emphasized broad-based adoption of its AI-powered HR tools and international platforms, which appears to be lifting client retention...

NorthWestern Energy Group (NWE) has affirmed its 2026 earnings guidance and long term rate base and EPS growth targets, following a fresh quarterly dividend declaration and its latest second quarter earnings report. See our latest analysis for NorthWestern Energy Group. Despite reaffirmed 2026 guidance and a fresh dividend declaration, NorthWestern Energy Group’s recent share price momentum has softened. The 7 day share price return is 4.69% and the 30 day share price return is 3.39%. This...

In late July 2026, West Pharmaceutical Services reported higher second-quarter sales of US$872.3 million and net income of US$154 million year over year, raised its full-year 2026 revenue outlook, and completed US$454.28 million of share repurchases under its February 2026 buyback program. Beyond the headline numbers, the company’s upgraded organic revenue guidance, tied to momentum in biologics and biosimilars-related products, signals growing confidence in its higher-value...

Escalating drone attacks on Russian logistics hubs and commercial shipping in the Black Sea are a stark reminder that geopolitical risk can ripple quickly through global supply chains, energy flows, and defense spending priorities. For investors, it raises the question of which stocks might benefit from higher demand for surveillance, counter drone technology, and secure logistics, and which could face greater operational risk. This article looks at 3 stocks from a Defense and Military...

In the past quarter, ORIC Pharmaceuticals, Inc. reported a second-quarter 2026 net loss of US$41.49 million, up from US$36.36 million a year earlier, while basic and diluted loss per share from continuing operations improved to US$0.38 from US$0.47. For the first half of 2026, net loss widened to US$77.26 million compared with US$66.38 million a year ago, yet basic and diluted loss per share narrowed to US$0.72 from US$0.89, highlighting the impact of a larger share count on per-share...

Hasbro (HAS) just reported second quarter 2026 results, with sales of US$1,139.6 million and net income of US$160.9 million, compared with sales of US$980.8 million and a net loss a year earlier. See our latest analysis for Hasbro. The latest quarterly results arrive after a mixed stretch for Hasbro’s stock, with the share price up 14.12% over the past month but down 6.17% over the past quarter, while the 1 year total shareholder return of 22.83% highlights stronger longer term momentum. If...

The latest move in Baldwin Insurance Group (BWIN) stock was driven by its Q2 2026 earnings release and fresh Q3 revenue guidance, which together reshaped how investors view growth and profitability. See our latest analysis for Baldwin Insurance Group. Over the past year Baldwin Insurance Group has delivered a mixed picture for investors, with a strong 90 day share price return of 43.18% and year to date share price return of 23.97% contrasting with a 1 year total shareholder return that...

Inspire Medical Systems stock is coming off a sharp three year share price decline, yet the current valuation checks paint a more balanced picture. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares are roughly in line with fair value, and the earnings and revenue multiples lean toward undervalued. The share price has fallen 78.7% over the past three years, which puts a heavy focus on whether the current level fairly reflects Inspire Medical Systems' long term cash...

Regeneron Pharmaceuticals, Inc. previously reported second-quarter 2026 revenue of US$4,290.7 million versus US$3,675.6 million a year earlier, while net income eased to US$1,296.9 million from US$1,391.6 million and diluted earnings per share from continuing operations slipped to US$12.23 from US$12.81. At the same time, the company affirmed a quarterly dividend of US$0.94 per share payable on August 31, 2026, underscoring its willingness to return cash to shareholders even as earnings...

Lam Research stock has delivered a very strong 402.9% return over the past five years, yet its current checks lean toward the shares looking expensive rather than like an obvious bargain. After a sharp recent move, investors are weighing that long run against signals that the valuation may be demanding. A roughly fivefold gain over five years suggests Lam Research has already priced in a lot of optimism about its role in the semiconductor cycle and AI related demand. Recent enthusiasm around...

Dover stock has already returned 47.9% over the past three years, and the latest intrinsic value work using a Discounted Cash Flow (DCF) approach still points to the shares trading at a discount to that estimate rather than at a clear premium. A 47.9% gain over three years suggests Dover has rewarded patient shareholders while still leaving the question of further upside open. The planned acquisition of Cloeren can support expectations for future cash flows, while the usual integration and...